Application of mass spectrometry to detect the level of psm-e molecules in urine in the preparation of products for early diagnosis of prostate cancer
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- 广州济士源生物技术有限公司
- Publication Date
- 2022-03-22
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the technical field of clinical inspection and diagnosis, in particular to the application of mass spectrometry technology to detect the level of PSM-E molecules in urine in preparing a product for early diagnosis of prostate cancer. Background technique
[0002] According to the "2020 National Cancer Center Annual Work Report", the incidence of prostate cancer in my country ranks ninth (total population), and the mortality rate ranks eighth (total population). The incidence of prostate cancer in my country is rising rapidly, and the age of onset is gradually younger. In addition, 60% to 70% of prostate cancer patients are locally advanced or advanced when they are first diagnosed. At present, there is a lack of accurate and convenient prostate cancer screening technology at home and abroad. Prostate specific membrane antigen (PSMA) is a transmembrane glycoprotein with the function of hydrolyzing folic acid and the neurotrans...